Arginine News and Research

RSS
Arginine is considered a semi-essential amino acid because even though the body normally makes enough of it, supplementation is sometimes needed. For example, people with protein malnutrition, excessive ammonia production, excessive lysine intake, burns, infections, peritoneal dialysis, rapid growth, urea synthesis disorders, or sepsis may not have enough arginine. Symptoms of arginine deficiency include poor wound healing, hair loss, skin rash, constipation, and fatty liver.

Arginine changes into nitric oxide, which causes blood vessel relaxation (vasodilation). Early evidence suggests that arginine may help treat medical conditions that improve with vasodilation, such as chest pain, clogged arteries (called atherosclerosis), coronary artery disease, erectile dysfunction, heart failure, intermittent claudication/peripheral vascular disease, and blood vessel swelling that causes headaches (vascular headaches). Arginine also triggers the body to make protein and has been studied for wound healing, bodybuilding, enhancement of sperm production (spermatogenesis), and prevention of wasting in people with critical illnesses.

Arginine hydrochloride has a high chloride content and has been used to treat metabolic alkalosis. This use should be under the supervision of a qualified healthcare professional.
New research could lead to diagnosis of preeclampsia in the first trimester

New research could lead to diagnosis of preeclampsia in the first trimester

FDA awards research grants to boost product development for patients with rare diseases

FDA awards research grants to boost product development for patients with rare diseases

People who eat high protein foods have lower blood pressure and arterial stiffness

People who eat high protein foods have lower blood pressure and arterial stiffness

Study may lead to effective antimicrobial treatment strategies for people with uncontrolled diabetes

Study may lead to effective antimicrobial treatment strategies for people with uncontrolled diabetes

Childhood cancer cells produce molecule that affects body's immune system to fight disease

Childhood cancer cells produce molecule that affects body's immune system to fight disease

ForeverGreen Worldwide earns BSCG's anti-doping certification for PowerStrips

ForeverGreen Worldwide earns BSCG's anti-doping certification for PowerStrips

Natural substance could help people avoid cavities, gum disease

Natural substance could help people avoid cavities, gum disease

New study identifies enzyme that causes obesity-related hypertension

New study identifies enzyme that causes obesity-related hypertension

Regular consumption of nuts reduce mortality by more than 20%

Regular consumption of nuts reduce mortality by more than 20%

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Peanuts may lower risk of deaths from heart disease

Peanuts may lower risk of deaths from heart disease

MD Anderson awarded more than $22 million in research grants from CPRIT

MD Anderson awarded more than $22 million in research grants from CPRIT

Discoveries by WA research team offer further treatment hope for victims of stroke

Discoveries by WA research team offer further treatment hope for victims of stroke

Doctor's Best adds three new sports nutrition powders to its science-based supplement portfolio

Doctor's Best adds three new sports nutrition powders to its science-based supplement portfolio

UAB Research Probes Molecular Basis Of Rare Genetic Disorder

UAB Research Probes Molecular Basis Of Rare Genetic Disorder

Researchers gain new insight into how motor neurons in the brain die during ALS

Researchers gain new insight into how motor neurons in the brain die during ALS

New study reveals how COX-2 inhibitors can increase risk of heart attack in arthritis patients

New study reveals how COX-2 inhibitors can increase risk of heart attack in arthritis patients

Epizyme's PRMT5 inhibitor shows efficacy in pre-clinical models of mantle cell lymphoma

Epizyme's PRMT5 inhibitor shows efficacy in pre-clinical models of mantle cell lymphoma

New treatment could halt growth of tumours in prostate cancer patients

New treatment could halt growth of tumours in prostate cancer patients

Discovery reveals promising target for treatment of end-stage heart failure

Discovery reveals promising target for treatment of end-stage heart failure